Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × Crizotinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 16 Lung Neoplasms 5 Neuroblastoma 3 Lymphoma 3 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Large-Cell, Anaplastic 2 Hematologic Neoplasms 2 Carcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Large Cell 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1 Advanced Cancer 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1 ALK-positive NSCLC 1 ALK or ROS1-positive NSCLC 1

Interventions

Cyclophosphamide 31 Dexamethasone 28 Cytarabine 20 fludarabine phosphate 18 Rituximab 18 Lenalidomide 16 Methotrexate 15 Bortezomib 15 fludarabine 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 pembrolizumab 12 Peripheral Blood Stem Cell Transplantation 12 Mycophenolic Acid 12 Etoposide 12 Melphalan 11 Gemcitabine 11 Filgrastim 11 Cyclosporine 11 Paclitaxel 10 pomalidomide 9 Carboplatin 9 Vincristine 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Busulfan 8 Brentuximab Vedotin 8 Bevacizumab 8 carfilzomib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡